ENA Respiratory has begun dosing participants in Part B of [...]

AstraZeneca is evaluating its oral IRAK4 inhibitor AZD6793 in a [...]

Amyl Therapeutics has raised €8.25m to generate preclinical data for [...]

L-glutamine combined with chemotherapy produced a 44% response rate in [...]

Karyopharm Therapeutics has submitted an application to the FDA seeking [...]

Early Phase 1b data show five objective responses among six [...]

A $2.5m National Institutes of Health award will support research [...]

The US Food and Drug Administration (FDA) has approved Mimrylo [...]

A systematic review of more than two decades of clinical [...]

ViiV Healthcare has received US FDA approval for Tivicay PD [...]